All Perspectives

International Trade & Investment Partner James Kim will lead a discussion at DesignCon 2026 on February 25th.

FDA Practice Leader and Agriculture & AgTech Industry Leader Karen Carr will present to the Plant Agriculture & Pesticide Regulations policy committee at the 2026 National Association of State Departments of Agriculture (NASDA) Winter Policy Conference on February 3, 2026.

International Trade & Investment Partner and Customs & Import Compliance Practice Leader Angela Santos will present on recent developments in international trade at ABA International Law Section’s The Americas Conference on January 27, 2026.

ArentFox Schiff’s Automotive Practice Group represented Sunroad Auto in selling its Kearny Mesa Genesis and Chrysler Dodge Jeep Ram dealerships to separate buyers.

ArentFox Schiff’s Automotive Practice Group represented Knight Automotive Group in selling Sunrise Ford Fontana and Sunrise Ford North Hollywood to GoAuto, a Canadian dealership group that has been expanding its US presence.

Since the Trump Administration’s tariff actions began in February 2025, the US hospitality industry has weathered the resulting uncertainty and shown resilience. The industry’s fundamentals remain broadly stable: deals are getting signed, and development continues — albeit with tighter underwriting and recalibrated budgets.

Partner J. Michael Showalter was quoted on how the Environmental Protection Agency’s (EPA) new “compliance first” doctrine may not mean less agency enforcement, despite concerns from environmental advocates.

The US Food and Drug Administration (FDA) issued an inspectional observation (Form FDA 483) to a Texas med spa, Pure Indulgence Aesthetics, citing Drug Supply Chain Security Act (DSCSA) violations for dispensers.

Bankruptcy law provides special treatment for landlord claims arising from termination of a lease, using a calculation set forth in Section 502(b)(6) of the Bankruptcy Code. The starting point for the calculation is to identify how and when the termination occurred.

Headlines that Matter for Companies and Executives in Regulated Industries

AFS Partners Todd Angkatavanich and Lauren Wolven will present at the 2026 Heckerling Institute on January 13-14, 2026 in Orlando, Florida.

The enforcement landscape entering 2026 points to sustained False Claims Act activity across traditional health care fraud, AI-enabled misconduct, civil rights–based claims, customs and tariff fraud, and expanding theories of investor liability.

The 2026 District of Columbia elections may be the most consequential elections since the advent of home rule in 1975. Against a backdrop of greater federal intervention into the city’s affairs, depleting federal resources, and local budget pressures, many of the city’s most important local offices will have new leadership after the elections in November.

Last month, the US Food and Drug Administration (FDA) issued a draft guidance explaining how it intends to implement the mandatory recall authority established under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).

The telehealth industry is entering a new phase of scrutiny marked by intensified enforcement actions across civil and criminal fronts that reflect a coordinated, whole-of-government approach.

A receivership is a court-supervised tool to stabilize operations of a distressed borrower, ring-fence pledged revenues, and drive recoveries for municipal bondholders when bankruptcy is not available or not desirable.

Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a mere four days before it was to go into effect.

As we approach the end of the first year of the second Trump Administration, many in the health care sector continue to closely watch federal enforcement trends to identify government priorities going forward.

Over the past year, both the executive branch and the courts sought to pare back certain stringent aspects of National Environmental Policy Act (NEPA) reviews. However, a decision issued in December 2025 illustrates that agencies cannot defer conducting NEPA-required reviews until after project approval.

On December 22, 2025, the US Department of Justice (DOJ) sued Stanley Black & Decker in the US District Court for the District of Maryland, alleging violations of the Consumer Product Safety Act (CPSA).

On December 16, 2025, the US Securities and Exchange Commission’s (SEC) Division of Examinations released a risk alert, “Additional Observations Regarding Advisers’ Compliance with the Advisers Act Marketing Rule.”

A federal judge in the Central District of California recently denied a surf apparel brand’s request to halt sales of Lady Gaga’s Mayhem album merchandise.

For the past several years, the use of contract sales forces by pharmaceutical and device manufacturers and other suppliers has been under a heightened enforcement spotlight.

The California Department of Public Health (CDPH) denied two petitions to amend the hospital licensing regulations in Title 22 of the California Code of Regulations to allow advanced practice providers to be members of organized medical staffs in general acute care hospitals.

For the first time in 26 years, the US Food and Drug Administration (FDA) has proposed adding a new active ingredient to the list of permissible sunscreen actives in the United States.